Fluoxetine hydrochloride for the treatment of severe refractory orthostatic hypotension
References (21)
- et al.
Postural hypotension: a report of three cases
Am Heart J.
(1925) - et al.
Management of chronic orthostatic hypotension
Am J Med
(1986) - et al.
Clonidine raises blood pressure in severe orthostatic hypotension
Am J Med.
(1983) - et al.
Syncope and orthostatic hypotension
Am J Med
(1991) - et al.
The use of anti-serotonergic agents for the treatment of acute hemorrhagic shock in cats
Eur J Pharmacol
(1985) - et al.
Response of obstructive sleep apnea to fluoxetine and protriptyline
Chest
(1991) - et al.
A neurological syndrome associated with orthostatic hypotension
Arch Neurol.
(1960) - et al.
Orthostatic hypotension—diagnosis and therapy
Mod Concepts Cardiovasc Disease
(1985) Orthostatic hypotension: clinical diagnosis, testing and treatment
Arch Int Med.
(1984)- et al.
Atrial tachypacing in the treatment of a patient with primary orthostatic hypotension
NEJM
(1980)
Cited by (59)
Cardiovascular autonomic neuropathy in patients with diabetes mellitus
2017, Revista Clinica EspanolaSyncope: Diagnosis and management
2015, Current Problems in CardiologyCitation Excerpt :Indications for drug therapy include the presence of multiple events or a single event resulting in injury.2 Medical therapy includes mineralocorticoids, vasoactive agents, acetylcholinesterase inhibitors, and serotonin antagonists.2,58-64 Beta-blockers have not been shown to be effective in 4 of 5 randomized trials and thus are no longer commonly used in the treatment of vasovagal syncope.
Orthostatic hypotension due to autonomic disorders in the hypertension clinic
2006, American Journal of HypertensionReversal of inappropriate peripheral vascular responses in hypertrophic cardiomyopathy
2005, Journal of the American College of CardiologyCitation Excerpt :Clonidine also appears to prevent acute reductions in sympathetic efferent activity in vasovagal syncope and in carotid sinus syndrome (34–37). Paroxetine is a highly selective serotonin (5HT) re-uptake inhibitor and has been shown to provide functional improvement in patients with vasovagal syncope (26–28). The mechanism by which this occurs is unclear, but animal and human evidence support a sudden increase in 5HT levels within the brainstem with activation of 5HT-2 receptors as a key to the mechanism of vasovagal syncope.